Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Shape Robotics A/S is a Denmark-based educational technology company specializing in intelligent classroom solutions and EdTech products that advance teaching through its TECHDUCATION philosophy. This approach integrates advanced technology into lessons to prepare students for future careers, emphasizing inclusivity for learners of all abilities, including those with special needs. Core offerings include the Fable modular robotic system for hands-on building in mechanics, electronics, and programming; Thinken, a compact mobile STEAM lab featuring robots, VR headsets, 3D printers, and charging stations; and comprehensive Smart Classrooms equipped with interactive displays, drones, laser cutters, and software tools. The company also provides Techducator, a platform with video training resources for educators. Revenue stems from Smart Classrooms, Fable robots, and other EdTech solutions, distributed via partnerships with national resellers targeting public institutions, primarily in Central and Eastern Europe such as Romania, Poland, and Moldova, bolstered by EU RRF funds, with expansion into the UK, USA, Middle East, and China. Founded in 2015 as a research spin-off and headquartered in Herlev, Denmark, Shape Robotics serves over 12,000 institutions worldwide, promoting STEAM education, sustainability, and practical learning skills.
DKK 0.64
+DKK 0.00 (+0.00%)
Price from 3 days ago
Operating margin is thin at 0.03%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue grew 76.3%, still solid. Margins contracted 2.7pp, which offsets some of the top-line progress.
ROIC dropped from 2.73% to 0.03%, capital efficiency is deteriorating. Negative free cash flow of -DKK 91M. The business is consuming cash, not generating it.
0.7x earnings. The multiple is below average. Either the market is pricing in deterioration you should investigate, or there's genuine value here.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
DKK 325M
▲ +76.3% YoY
Net Income (TTM)
DKK 13M
▼ -646.8% YoY
Op. Margin
12.99%
▼ -2.7pp YoY
ROIC
0.03%
▼ -2.7pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-DKK 111M
▼ -37.0% YoY
Op. Cash Flow (TTM)
-DKK 56M
▼ -50.0% YoY
Net Debt
DKK 136M
Cash & Equiv.
DKK 4M
3Y CAGR: +154.9%
Continue Research
At a P/E of 0.7, Shape Robotics A/S (SHAPE.XCSE)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Shape Robotics A/S scores 40/100 on Intrinsiqq's quality scorecard, weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full . This is analysis, not investment advice.
Shape Robotics A/S scores 40 out of 100 on Intrinsiqq's quality score, a weighted blend of 7 metrics each scored 0 to 100, which makes it a mixed business on these measures. Recent fundamentals include a 13.0% operating margin and a 0.0% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. you should weigh SHAPE.XCSE's valuation and scores 40/100 on quality (mixed). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.